Literature DB >> 1588179

The role of complement in the host's defense against Haemophilus influenzae.

J A Winkelstein1, E R Moxon.   

Abstract

In vitro studies have shown that Haemophilus influenzae type b (Hib) can activate both the classical and alternative pathways of complement and generate complement-dependent opsonic and bactericidal activities. In vivo studies and observations in complement-deficient patients have established the biologic significance of complement in the host's defense against H. influenzae. The complement system plays a significant role in the host's defense against Hib and against other encapsulated and unencapsulated H. influenzae, mainly by enhancing clearance from the bloodstream through its action as an opsonin in both nonimmune and immune hosts. Patients with genetically determined deficiencies of C3 or of the complement components involved in C3 activation have an increased susceptibility to H. influenzae. More recently, a relatively common deficiency of one isotype of C4 (C4B) has been shown to be associated with invasive Hib disease, suggesting that defects in complement-mediated host defense may be more common in systemic Hib infections than previously appreciated.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1588179     DOI: 10.1093/infdis/165-supplement_1-s62

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  9 in total

1.  Systemic humoral immunity to non-typeable Haemophilus influenzae.

Authors:  P T King; J Ngui; D Gunawardena; P W Holmes; M W Farmer; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2008-09       Impact factor: 4.330

2.  ArcA-regulated glycosyltransferase lic2B promotes complement evasion and pathogenesis of nontypeable Haemophilus influenzae.

Authors:  Sandy M S Wong; Frank St Michael; Andrew Cox; Sanjay Ram; Brian J Akerley
Journal:  Infect Immun       Date:  2011-02-28       Impact factor: 3.441

Review 3.  Advances in combating fungal diseases: vaccines on the threshold.

Authors:  Jim E Cutler; George S Deepe; Bruce S Klein
Journal:  Nat Rev Microbiol       Date:  2006-12-11       Impact factor: 60.633

Review 4.  Haemophilus influenzae type b conjugate vaccines.

Authors:  Dominic F Kelly; E Richard Moxon; Andrew J Pollard
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

5.  Outer membrane protein P5 is required for resistance of nontypeable Haemophilus influenzae to both the classical and alternative complement pathways.

Authors:  Charles V Rosadini; Sanjay Ram; Brian J Akerley
Journal:  Infect Immun       Date:  2013-11-25       Impact factor: 3.441

6.  A fine-tuned interaction between trimeric autotransporter haemophilus surface fibrils and vitronectin leads to serum resistance and adherence to respiratory epithelial cells.

Authors:  Birendra Singh; Yu-Ching Su; Tamim Al-Jubair; Oindrilla Mukherjee; Teresia Hallström; Matthias Mörgelin; Anna M Blom; Kristian Riesbeck
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

Review 7.  Mechanism of meningeal invasion by Neisseria meningitidis.

Authors:  Mathieu Coureuil; Olivier Join-Lambert; Hervé Lécuyer; Sandrine Bourdoulous; Stefano Marullo; Xavier Nassif
Journal:  Virulence       Date:  2012-03-01       Impact factor: 5.882

Review 8.  Linking Susceptibility to Infectious Diseases to Immune System Abnormalities among HIV-Exposed Uninfected Infants.

Authors:  Candice Ruck; Brian A Reikie; Arnaud Marchant; Tobias R Kollmann; Fatima Kakkar
Journal:  Front Immunol       Date:  2016-08-19       Impact factor: 7.561

9.  First Necrotizing Fasciitis Caused by Haemophilus influenza Serotype a.

Authors:  Giang T Quach; Jared Frisby; Kurt Kralovich; Mustafa Bohra
Journal:  J Investig Med High Impact Case Rep       Date:  2017-10-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.